New ultrasound biopsy could replace risky lung surgery for scarred lungs

NCT ID NCT07305220

First seen Jan 09, 2026 · Last updated Jun 19, 2026 · Updated 23 times

Summary

This study tests whether an ultrasound-guided needle biopsy is a safe way to diagnose interstitial lung disease (ILD), a group of conditions that scar the lungs. Fifteen adults who need a tissue sample will first get the ultrasound-guided biopsy under local anesthesia, then have the standard surgical biopsy. Researchers will track serious complications like collapsed lung or bleeding to see if the less invasive method is safe enough to use routinely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pneumology department

    Tours, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ultrasound-guided lung biopsy

What this could lead to

If this procedure proves safe, it could offer a less risky, outpatient alternative to surgical lung biopsy for diagnosing interstitial lung disease.

What could go wrong

This is a very small, early feasibility study with only 15 people. The procedure may still cause complications like collapsed lung or bleeding, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.